Literature DB >> 20803107

Orbital inflammatory pseudotumors: etiology, differential diagnosis, and management.

Gabriela M Espinoza1.   

Abstract

Orbital inflammation is typically an idiopathic process that occasionally may be identified with a specific local or systemic disease as the causative agent. Orbital inflammatory pseudotumor (also known as idiopathic orbital inflammation syndrome, orbital pseudotumor, nonspecific orbital inflammation, and orbital inflammatory syndrome) is defined as an idiopathic tumor-like inflammation consisting of a pleomorphic cellular response and a fibrovascular tissue reaction. Various rheumatologic disorders are associated with orbital inflammation and must be ruled out in cases of orbital inflammatory pseudotumor, including Wegener's granulomatosis, giant cell arteritis, systemic lupus erythematosus, dermatomyositis, and rheumatoid arthritis. The mainstay of therapy is corticosteroid therapy, although there is an increasing trend toward use of antimetabolites, alkylating agents, cytotoxic agents, and other immunosuppressive agents.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20803107     DOI: 10.1007/s11926-010-0128-8

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  33 in total

1.  Short-term use of Infliximab in a case of recalcitrant idiopathic orbital inflammatory disease.

Authors:  Sarah F Osborne; Jo L Sims; Paul M Rosser
Journal:  Clin Exp Ophthalmol       Date:  2009-12       Impact factor: 4.207

2.  Orbital myositis following streptococcal pharyngitis.

Authors:  Mohamed Alshaikh; Alyson M Kakakios; Andrew S Kemp
Journal:  J Paediatr Child Health       Date:  2008-04       Impact factor: 1.954

3.  Idiopathic orbital myositis: treatment with cyclosporin.

Authors:  J Sánchez-Román; J M Varela-Aguilar; J Bravo-Ferrer; E Sequeiros Madueño; M Fernández de Bobadilla
Journal:  Ann Rheum Dis       Date:  1993-01       Impact factor: 19.103

4.  A role for methotrexate in the management of non-infectious orbital inflammatory disease.

Authors:  J R Smith; J T Rosenbaum
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

Review 5.  What is orbital pseudotumor?

Authors:  I Mombaerts; R Goldschmeding; R O Schlingemann; L Koornneef
Journal:  Surv Ophthalmol       Date:  1996 Jul-Aug       Impact factor: 6.048

6.  Low-dose cyclosporine therapy of granulomatous optic neuropathy and orbitopathy.

Authors:  L Bielory; L P Frohman
Journal:  Ophthalmology       Date:  1991-11       Impact factor: 12.079

7.  Infliximab in the treatment of recalcitrant idiopathic orbital inflammation.

Authors:  Matthew W Wilson; William J Shergy; Barrett G Haik
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2004-09       Impact factor: 1.746

8.  The use of infliximab in ocular inflammation.

Authors:  C Prendiville; M O'Doherty; P Moriarty; L Cassidy
Journal:  Br J Ophthalmol       Date:  2008-04-11       Impact factor: 4.638

Review 9.  Long-term safety of mycophenolate mofetil and cyclosporine: a review.

Authors:  Catherine Buell; John Koo
Journal:  J Drugs Dermatol       Date:  2008-08       Impact factor: 2.114

10.  Radiotherapy for idiopathic inflammatory orbital pseudotumor. Indications and results.

Authors:  R C Sergott; J S Glaser; K Charyulu
Journal:  Arch Ophthalmol       Date:  1981-05
View more
  25 in total

Review 1.  Systemic immunoglobulin G4 (IgG4) disease and idiopathic orbital inflammation; removing 'idiopathic' from the nomenclature?

Authors:  D Lindfield; K Attfield; A McElvanney
Journal:  Eye (Lond)       Date:  2012-02-03       Impact factor: 3.775

2.  Recurrent orbital space-occupying lesions: a clinicopathologic study of 253 cases.

Authors:  Weiqiang Tang; Yan Hei; Lihua Xiao
Journal:  Chin J Cancer Res       Date:  2013-08       Impact factor: 5.087

Review 3.  The great mimicker: IgG4-related disease.

Authors:  Rodolfo Perez Alamino; Luis R Espinoza; Arnold H Zea
Journal:  Clin Rheumatol       Date:  2013-07-23       Impact factor: 2.980

Review 4.  Ocular vasculitis.

Authors:  Gabriela M Espinoza; Ankit Desai; Levent Akduman
Journal:  Curr Rheumatol Rep       Date:  2013-09       Impact factor: 4.592

5.  Relationship between dacryoadenitis subtype of idiopathic orbital inflammatory pseudotumor and paranasal sinusitis.

Authors:  Jing Li; Xin Ge; Jian-Min Ma
Journal:  Int J Ophthalmol       Date:  2016-03-18       Impact factor: 1.779

6.  Orbital lymphoproliferative disorders (OLPDs): value of MR imaging for differentiating orbital lymphoma from benign OPLDs.

Authors:  K Haradome; H Haradome; Y Usui; S Ueda; T C Kwee; K Saito; K Tokuuye; J Matsubayashi; T Nagao; H Goto
Journal:  AJNR Am J Neuroradiol       Date:  2014-05-29       Impact factor: 3.825

7.  Intraorbital injection of Rituximab in idiopathic orbital inflammatory syndrome: case reports.

Authors:  Gustavo Savino; Remo Battendieri; Andrea Siniscalco; Erika Mandarà; Antonino Mulè; Gianluigi Petrone; Salvatore Traina; Monica Riso
Journal:  Rheumatol Int       Date:  2014-05-31       Impact factor: 2.631

8.  Orbital Apex Lesions: A Diagnostic and Therapeutic Challenge.

Authors:  Sung-Woo Cho; Won-Wook Lee; Dae Joong Ma; Ji-Hoon Kim; Doo Hee Han; Hyun Jik Kim; Dong-Young Kim; Seong-Joon Kim; Sang In Khwarg; Sung-Min Kim; Sun Ha Paek; Chae-Seo Rhee; Chul Hee Lee; Peter H Hwang; Tae-Bin Won
Journal:  J Neurol Surg B Skull Base       Date:  2017-12-13

Review 9.  Bilateral orbital pseudotumor in a patient with Takayasu arteritis: a case report and review of the literature.

Authors:  Ali Taylan; Burak Karakas; Aytac Gulcu; Merih Birlik
Journal:  Rheumatol Int       Date:  2016-02-04       Impact factor: 2.631

10.  ORBITAL PSEUDOTUMOR CAN MIMIC GRAVES' OPHTHALMOPATHY.

Authors:  M Stanciu; F L Popa; I G Totoian; L G Bera
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Jul-Sep       Impact factor: 0.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.